MENU
+Compare
PTCT
Stock ticker: NASDAQ
AS OF
Nov 26 closing price
Price
$86.25
Change
+$3.32 (+4.00%)
Capitalization
6.92B

PTCT PTC Therapeutics Forecast, Technical & Fundamental Analysis

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders... Show more

Industry: #Biotechnology
PTCT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for PTCT with price predictions
Nov 26, 2025

PTCT's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for PTCT turned positive on November 06, 2025. Looking at past instances where PTCT's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 04, 2025. You may want to consider a long position or call options on PTCT as a result. In of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PTCT advanced for three days, in of 269 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 191 cases where PTCT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 15 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 13 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PTCT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

PTCT broke above its upper Bollinger Band on November 24, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PTCT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock slightly better than average.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (27.303). P/E Ratio (10.028) is within average values for comparable stocks, (52.392). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.898). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (4.095) is also within normal values, averaging (331.437).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
PTCT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

PTCT is expected to report earnings to fall 553.50% to -90 cents per share on February 24

PTC Therapeutics PTCT Stock Earnings Reports
Q4'25
Est.
$-0.91
Q3'25
Beat
by $1.32
Q2'25
Beat
by $0.23
Q1'25
Beat
by $11.07
Q4'24
Missed
by $0.06
The last earnings report on November 04 showed earnings per share of 20 cents, beating the estimate of -112 cents. With 15.47M shares outstanding, the current market capitalization sits at 6.92B.
A.I. Advisor
published General Information

General Information

a developer of biopharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
100 Corporate Court
Phone
+1 908 222-7000
Employees
1058
Web
https://www.ptcbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JSVQX30.550.27
+0.89%
JPMorgan Small Cap Value R4
RNPHX73.600.55
+0.75%
American Funds New Perspective R5E
DYGAX15.770.11
+0.70%
Meeder Dynamic Allocation Adviser
LSNGX24.420.12
+0.49%
Loomis Sayles Global Growth N
APHYX24.060.04
+0.17%
Artisan Developing World Institutional

PTCT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PTCT has been loosely correlated with CGON. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if PTCT jumps, then CGON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTCT
1D Price
Change %
PTCT100%
+4.00%
CGON - PTCT
45%
Loosely correlated
-1.47%
ACLX - PTCT
45%
Loosely correlated
+0.34%
BEAM - PTCT
43%
Loosely correlated
+1.38%
SYRE - PTCT
43%
Loosely correlated
+1.88%
XNCR - PTCT
43%
Loosely correlated
+0.70%
More